A Food and Drug Administration (FDA) advisory committee will hold a meeting to discuss Merck and Ridgeback Biotherapeutics’ COVID-19 antiviral pill on Tuesday morning.
The event is scheduled to begin at 9 a.m. ET.
Watch the live video above.
A Food and Drug Administration (FDA) advisory committee will hold a meeting to discuss Merck and Ridgeback Biotherapeutics’ COVID-19 antiviral pill on Tuesday morning.
The event is scheduled to begin at 9 a.m. ET.
Watch the live video above.